FermaVir Announces New Preclinical Oral Bioavailability Data for

FermaVir Announces New Preclinical Oral Bioavailability Data for
Business Wire (press release), CA - 6 hours ago that has demonstrated powerful inhibitory activity and may have potential therapeutic benefit for the treatment of shingles, also known as herpes zoster.

Merck Says Data Reveal JANUVIA Is Non-inferior To Glipizide In
Trading Markets, CA - Jun 13, 2006 Additionally, treatment with JANUVIA improved measures of beta cell function, the company said. for its new vaccine ZOSTAVAX for prevention of herpes zoster in

New data from the United States, Netherlands and United Kingdom
Therapeutics Daily (subscription) (press release), PA - Jun 13, 2006 on cancer treatment are outlined in reports from the United States, Netherlands and United Kingdom. Study 1: The efficacy of an oncolytic herpes simplex virus

Amarillo Biosciences to Hold Annual Meeting on June 22, 2006
Market Wire (press release) - Jun 15, 2006 biotech company with basic research programs in adenovirus and herpes virus vectors the use of low-dose, orally administered interferon as a treatment for a

Herpes